These results indicate that the BAIBA reduces blood glucose and hepatic gluconeogenesis and improves hepatic insulin resistance in type 2 diabetes, which is associated with the improvement of insulin signaling rather than the circulating insulin levels. This evidence concerns the gene INS and type 2 diabetes mellitus.